FindTrial
Sign In

Tenofovir disoproxil fumarate 300mg

DRUG6 trials

Sponsors

Inje University, Third Affiliated Hospital, Sun Yat-Sen University, Yonsei University, Sun Yat-sen University, Samjin Pharmaceutical Co., Ltd.

Conditions

Antiviral Drug Adverse ReactionChronic Hepatitis BChronic Hepatitis bHealthy VolunteersHepatitis BHepatitis B, ChronicHepatocellular Carcinoma Recurrent

Phase 1

The Effect of PAS on the Pharmacokinetics of Tenofovir in Healthy Subjects
NCT03070405
Inje UniversityHealthy Volunteers
Start: 2016-10-31End: 2017-05-31Target: 20Updated: 2017-03-03

Phase 3

A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection
NCT04392700
Sun Yat-sen UniversityHepatocellular Carcinoma Recurrent
Start: 2019-07-25End: 2024-07-25Target: 706Updated: 2020-05-19

Phase 4

The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation
CompletedNCT03468907
Third Affiliated Hospital, Sun Yat-Sen UniversityHepatitis B, Chronic
Start: 2015-06-01End: 2017-12-31Updated: 2018-08-29
A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B
CompletedNCT05282407
Samjin Pharmaceutical Co., Ltd.Chronic Hepatitis B
Start: 2017-11-20End: 2019-04-17Updated: 2022-04-01
Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B
CompletedNCT05286346
Samjin Pharmaceutical Co., Ltd.Chronic Hepatitis b
Start: 2018-10-12End: 2020-08-10Updated: 2025-05-16

Unknown Phase

Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral Resistance
NCT03566030
Yonsei UniversityAntiviral Drug Adverse Reaction, Hepatitis B
Start: 2018-09-01End: 2020-08-31Target: 300Updated: 2018-06-21